UnitedHealthcareHigh ImpactCoverage
Changes to injectable oncology drug coverage are coming
Published June 3, 2026Effective September 1, 2026
AI Summary
Starting September 1, 2026, UnitedHealthcare will exclude certain brand-name injectable oncology drugs from medical benefit coverage when generic alternatives are available. Prior authorization will still be required for both excluded drugs and their generic alternatives.
Action Required
By September 1, 2026: Billing team must update system to flag excluded injectable oncology drugs (J0185, J1434, J2468, J9054, J9072, J9074, J9076, J9172, J9292, J9304, J9324, J9999) and transition to generic alternatives. Update prior authorization workflows to include both excluded and alternative drugs. Providers must transition existing patients from excluded drugs to covered alternatives when current authorizations expire.
Affected Billing Codes
J0185J1453J1434J2468J2469J9054J9051J9049J9041J9072J9073J9071J9075J9074J9076J9172J9171J9292J9305J9314J9322J9323J9296J9294J9297J9304J9324J9999J9201J9196
Plan Types
Commercial
Specialties
oncology, hematology